Stay updated on Archway Study: PDS vs Monthly Ranibizumab in Wet AMD Clinical Trial
Sign up to get notified when there's something new on the Archway Study: PDS vs Monthly Ranibizumab in Wet AMD Clinical Trial page.

Latest updates to the Archway Study: PDS vs Monthly Ranibizumab in Wet AMD Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedRevision: v3.5.4 replaced Revision: v3.5.3 as the page revision. This update does not alter visible content or user-facing features.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check38 days agoChange DetectedUpdated the ClinicalTrials.gov page revision indicator from v3.5.2 to v3.5.3, reflecting a platform/software version change rather than a change to the study details.SummaryDifference0.0%

- Check45 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check74 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0. No changes to study details or page content are introduced.SummaryDifference0.0%

- Check88 days agoChange DetectedRevision: v3.4.3 added to the site; it replaces the previous v3.4.2.SummaryDifference0.0%

- Check109 days agoChange DetectedRevision: v3.4.2 replaces v3.4.1; no study content, eligibility criteria, or user-facing information appear to have changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Archway Study: PDS vs Monthly Ranibizumab in Wet AMD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Archway Study: PDS vs Monthly Ranibizumab in Wet AMD Clinical Trial page.